Article

Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution

Broad Institute, Cambridge, Massachusetts, USA.
Nature Methods (Impact Factor: 25.95). 02/2010; 7(2):133-6. DOI: 10.1038/nmeth.1414
Source: PubMed

ABSTRACT Bisulfite sequencing measures absolute levels of DNA methylation at single-nucleotide resolution, providing a robust platform for molecular diagnostics. We optimized bisulfite sequencing for genome-scale analysis of clinical samples: here we outline how restriction digestion targets bisulfite sequencing to hotspots of epigenetic regulation and describe a statistical method for assessing significance of altered DNA methylation patterns. Thirty nanograms of DNA was sufficient for genome-scale analysis and our protocol worked well on formalin-fixed, paraffin-embedded samples.

Download full-text

Full-text

Available from: Natalie Jäger, Dec 28, 2013
1 Follower
 · 
190 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Methods for single-cell genome and transcriptome sequencing have contributed to our understanding of cellular heterogeneity, whereas methods for single-cell epigenomics are much less established. Here, we describe a whole-genome bisulfite sequencing (WGBS) assay that enables DNA methylation mapping in very small cell populations (μWGBS) and single cells (scWGBS). Our assay is optimized for profiling many samples at low coverage, and we describe a bioinformatic method that analyzes collections of single-cell methylomes to infer cell-state dynamics. Using these technological advances, we studied epigenomic cell-state dynamics in three in vitro models of cellular differentiation and pluripotency, where we observed characteristic patterns of epigenome remodeling and cell-to-cell heterogeneity. The described method enables single-cell analysis of DNA methylation in a broad range of biological systems, including embryonic development, stem cell differentiation, and cancer. It can also be used to establish composite methylomes that account for cell-to-cell heterogeneity in complex tissue samples. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Motivation: DNA methylation plays critical roles in gene regulation and cellular specification without altering DNA sequences. The wide application of reduced representation bisulfite sequencing (RRBS) and whole genome bisulfite sequencing (bis-seq) opens the door to study DNA methylation at single CpG site resolution. One challenging question is how best to test for significant methylation differences between groups of biological samples in order to minimize false positive findings. Results: We present a statistical analysis package, methylSig, to analyse genome-wide methylation differences between samples from different treatments or disease groups. MethylSig takes into account both read coverage and biological variation by utilizing a beta-binomial approach across biological samples for a CpG site or region, and identifies relevant differences in CpG methylation. It can also incorporate local information to improve group methylation level and/or variance estimation for experiments with small sample size. A permutation study based on data from enhanced RRBS samples shows that methylSig maintains a well-calibrated type-I error when the number of samples is three or more per group. Our simulations show that methylSig has higher sensitivity compared with several alternative methods. The use of methylSig is illustrated with a comparison of different subtypes of acute leukemia and normal bone marrow samples.
    Bioinformatics 05/2014; 30(17). DOI:10.1093/bioinformatics/btu339 · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The rapid development of high-throughput sequencing technologies has enabled epigeneticists to quantify DNA methylation on a massive scale. Progressive increases in sequencing capacity present challenges in terms of processing analysis and the interpretation of the large amount of data, investigating differential methylation between genome-scale data from multiple samples highlights this challenge. We have developed a differential methylation analysis package (DMAP) to generate coverage-filtered reference methylomes and identify differentially methylated regions across multiple samples from reduced representation (RRBS) and whole genome bisulphite sequencing (WGBS) experiments. We introduce a novel fragment-based approach for investigating DNA methylation patterns for RRBS data. Further, DMAP provides the identity of gene and CpG features and distances to the differentially methylated regions in a format that is easily analysed with limited bioinformatics knowledge. The software has been implemented in C and has been written to ensure portability between different platforms. The source code and documentation is freely available (DMAP: as compressed TAR archive folder) from http://biochem.otago.ac.nz/research/databases-software/. Two test datasets are also available for download from the website. Test dataset 1 contains reads from chromosome 1 of a patient and a control, which is used, for comparative analysis in the current article. Test dataset 2 contains reads from a part of chromosome 21 of three disease and three control samples for testing the operation of DMAP, especially for the analysis of variance (ANOVA). Example commands for the analyses are included.Contact: peter.stockwell@otago.ac.nz; aniruddha.chatterjee@otago.ac.nzSupplementary Information: Supplementary data are available at Bioinformatics online.
    Bioinformatics 03/2014; 30(13). DOI:10.1093/bioinformatics/btu126 · 4.62 Impact Factor